03:25 AM EDT, 09/11/2024 (MT Newswires) -- Michael J. Farrell, Chief Executive Officer, on September 09, 2024, sold 14,683 shares in ResMed ( RMD ) for $3,646,950. Following the Form 4 filing with the SEC, Farrell has control over a total of 468,259 shares of the company, with 464,169 shares held directly and 4,090 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/943819/000112760224023757/xslF345X05/form4.xml
Price: 253.00, Change: +0.14, Percent Change: +0.06